Scisparc Ltd

詳細情報 Scisparc Ltd 企業名

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

企業情報

企業コードSPRC

会社名Scisparc Ltd

上場日Dec 22, 2021

最高経営責任者「CEO」Mr. Amitay Weiss

従業員数2

証券種類Ordinary Share

決算期末Dec 22

本社所在地20 Raul Wallenberg Street, Tower A

都市TEL AVIV-YAFO

証券取引所NASDAQ Capital Market Consolidated

国Israel

郵便番号6971916

電話番号97236103100

ウェブサイトhttps://scisparc.com/

企業コードSPRC

上場日Dec 22, 2021

最高経営責任者「CEO」Mr. Amitay Weiss

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Itschak Shrem

Chairman of the Board

16.00

+128.57%

Mr. Amitay Weiss

Chief Executive Officer, Director

1.00

--

Prof. Ari Shamiss, M.D.

Independent Director

--

Mr. Alon Dayan

Independent Director

--

Dr. Adi Zuloff-Shani

Chief Technology Officer

--

Mr. Amnon Shay

Independent Director

--

Mr. Moshe Revach

Director

--

Mr. Lior Vider

Independent Director

--

Ms. Liat Sidi

Director

--

Mr. Oz Adler, CPA

Chief Financial Officer

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Itschak Shrem

Chairman of the Board

16.00

+128.57%

Mr. Amitay Weiss

Chief Executive Officer, Director

1.00

--

Prof. Ari Shamiss, M.D.

Independent Director

--

Mr. Alon Dayan

Independent Director

--

Dr. Adi Zuloff-Shani

Chief Technology Officer

--

Mr. Amnon Shay

Independent Director

--

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Wed, May 21

株主統計

種類

株主統計

比率

UBS Financial Services, Inc.

0.20%

Yorkville Advisors Global, LP.

0.16%

Renaissance Technologies LLC

0.13%

他の

99.51%

株主統計

比率

UBS Financial Services, Inc.

0.20%

Yorkville Advisors Global, LP.

0.16%

Renaissance Technologies LLC

0.13%

他の

99.51%

種類

株主統計

比率

Investment Advisor

0.20%

Investment Advisor/Hedge Fund

0.16%

Hedge Fund

0.13%

他の

99.51%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

20

5.89K

1.10%

-4.32K

2025Q1

22

123.94K

1.13%

-90.52K

2024Q4

22

186.52K

1.22%

-6.68K

2024Q3

20

179.36K

1.73%

+90.02K

2024Q2

22

138.03K

12.19%

+104.31K

2024Q1

20

67.89K

2.29%

+37.60K

2023Q4

19

11.96K

4.65%

-10.95K

2023Q3

23

5.71K

4.48%

-17.08K

2023Q2

22

12.21K

6.80%

-11.05K

2023Q1

20

14.22K

7.92%

-4.38K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

UBS Financial Services, Inc.

--

0%

-2.27K

-100.00%

Mar 31, 2025

Yorkville Advisors Global, LP.

2.63K

0.49%

+2.63K

--

Feb 27, 2024

Renaissance Technologies LLC

--

0%

-1.89K

-100.00%

Sep 30, 2024

SBI Securities Co., Ltd.

14.00

0%

+11.00

+366.67%

Mar 31, 2025

Shrem (Itschak)

16.00

0%

+9.00

+128.57%

Apr 23, 2025

Rhumbline Advisers Ltd. Partnership

1.00

0%

-164.00

-99.39%

Mar 31, 2025

BofA Global Research (US)

2.00

0%

-4.00

-66.67%

Mar 31, 2025

Weiss (Amitay)

1.00

0%

--

Apr 23, 2025

J.P. Morgan Securities LLC

--

0%

-22.00

-100.00%

Mar 31, 2025

Morgan Stanley & Co. LLC

--

0%

-18.00

-100.00%

Mar 31, 2025

詳細を見る

4.770USD

Scisparc Ltd

4.770

概要

企業名

金融

分析